BLITZIMA

Welcome to the Brand page for “BLITZIMA”, which is offered here for Pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammations; pharmaceutical preparations for the treatment of transplant rejection; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases;blitz ima;.

Its status is currently believed to be active. Its class is unavailable. “BLITZIMA” is believed to be currently owned by “Celltrion, Inc.”